Clinical Trial Update: Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating pembrolizumab in combination with chemotherapy for frail patients with classic Hodgkin lymphoma who are ineligible for standard tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Hodgkin Lymphoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Classic Hodgkin Lymphoma | Phase 2 | Status: RECRUITING